{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T16:41:35Z","timestamp":1779900095614,"version":"3.53.1"},"reference-count":68,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Acute kidney injury (AKI) in the setting of hematopoietic stem cell transplantation (HSCT) is common in pediatric and adult patients. The incidence ranges from 12 to 66%, and development of AKI in the posttransplant course is independently associated with higher mortality.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Patients who undergo HSCT have many risk factors for developing AKI, including sepsis, use of nephrotoxic medications, graft versus host disease (GVHD), and veno-occlusive disease (VOD). In addition, engraftment syndrome\/cytokine storm, transplant-associated thrombotic microangiopathy (TA-TMA), and less common infections with specific renal manifestations, such as BK and adenovirus nephritis, may lead to kidney injury. There has been significant advancement in the understanding of TA-TMA in particular, especially the role of the complement system in its pathophysiology. The role of early dialysis has been explored in the pediatric population, but not well studied in adult HSCT recipients<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>This review provides an update on the risk factors, causes, and treatment approaches to HSCT-associated AKI.<\/jats:p>\n            <jats:p>\n                                 <jats:bold>Video abstract<\/jats:bold>\n                                 http:\/\/links.lww.com\/COCC\/A29\n                              <\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mcc.0000000000000657","type":"journal-article","created":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T05:39:11Z","timestamp":1568439551000},"page":"531-538","source":"Crossref","is-referenced-by-count":30,"title":["Acute kidney injury in hematopoietic stem cell transplantation"],"prefix":"10.1097","volume":"25","author":[{"given":"Rimda","family":"Wanchoo","sequence":"first","affiliation":[{"name":"Division of Kidney Diseases and Hypertension"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian R.","family":"Stotter","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Pediatrics, Washington University School of Medicine, St Louis, MO, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruthee L.","family":"Bayer","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Northwell Cancer Institute, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell, Great Neck, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenar D.","family":"Jhaveri","sequence":"additional","affiliation":[{"name":"Division of Kidney Diseases and Hypertension"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230913","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"R2-20230913","doi-asserted-by":"crossref","first-page":"194","DOI":"10.5045\/br.2015.50.4.194","article-title":"Hematopoietic stem cell expansion and generation: the ways to make a breakthrough","volume":"50","author":"Park","year":"2015","journal-title":"Blood Res"},{"key":"R3-20230913","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S0140-6736(00)03561-3","article-title":"Renal failure after bone-marrow transplantation","volume":"357","author":"Cohen","year":"2001","journal-title":"Lancet"},{"key":"R4-20230913","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1182\/blood-2008-03-077974","article-title":"Graft-versus-leukemia effects of transplantation and donor lymphocytes","volume":"112","author":"Kolb","year":"2008","journal-title":"Blood"},{"key":"R5-20230913","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/00007890-199105000-00016","article-title":"Interaction between cyclosporine and fluconazole in renal allograft recipients","volume":"51","author":"Canafax","year":"1991","journal-title":"Transplantation"},{"key":"R6-20230913","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1086\/598327","article-title":"Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents","volume":"48","author":"Br\u00fcggemann","year":"2009","journal-title":"Clin Infect Dis"},{"key":"R7-20230913","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1038\/bmt.2009.377","article-title":"A comparative assessment of the RIFLE, AKIN and conventional criteria for acute kidney injury after hematopoietic SCT","volume":"45","author":"Ando","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R8-20230913","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/s41409-017-0030-3","article-title":"Acute kidney injury following haplo stem cell transplantation: incidence, risk factors and outcome","volume":"53","author":"Liu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"R9-20230913","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/hon.2141","article-title":"A double-blind, randomized, controlled trial on N-acetylcysteine for the prevention of acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"33","author":"Ataei","year":"2015","journal-title":"Hematol Oncol"},{"key":"R10-20230913","doi-asserted-by":"crossref","first-page":"225","DOI":"10.5414\/CN107280","article-title":"Changes in renal function in long-term survivors of allogeneic hematopoietic stem-cell transplantation: single-center experience","volume":"77","author":"Kang","year":"2012","journal-title":"Clin Nephrol"},{"key":"R11-20230913","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bmt.1705412","article-title":"Early renal injury after myeloablative allogeneic and autologous hematopoietic cell transplantation","volume":"38","author":"Caliskan","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R12-20230913","doi-asserted-by":"crossref","first-page":"e6467","DOI":"10.7717\/peerj.6467","article-title":"Incidence of acute kidney disease after receiving hematopoietic stem cell transplantation: a single-center retrospective study","volume":"7","author":"Mima","year":"2019","journal-title":"PeerJ"},{"key":"R13-20230913","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/bmt.2008.207","article-title":"Contemporary analysis of the influence of acute kidney injury after reduced intensity conditioning haematopoietic cell transplantation on long-term survival","volume":"42","author":"Lopes","year":"2008","journal-title":"Bone Marrow Transplant"},{"key":"R14-20230913","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bmt.2009.99","article-title":"A multicenter, retrospective study of acute kidney injury in adult patients with nonmyeloablative hematopoietic SCT","volume":"45","author":"Liu","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"R15-20230913","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1002\/cam4.2187","article-title":"Incidence and risk factors for acute kidney injury following autologous stem cell transplantation for multiple myeloma","volume":"8","author":"Andronesi","year":"2019","journal-title":"Cancer Med"},{"key":"R16-20230913","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5000055","article-title":"Acute renal failure in hematopoietic cell transplantation","volume":"69","author":"Parikh","year":"2006","journal-title":"Kidney Int"},{"key":"R17-20230913","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1523-1755.2005.00078.x","article-title":"Acute renal failure after myeloablative hematopoietic cell transplant: incidence and risk factors","volume":"67","author":"Hingorani","year":"2005","journal-title":"Kidney Int"},{"key":"R18-20230913","doi-asserted-by":"crossref","first-page":"e27038","DOI":"10.1002\/pbc.27038","article-title":"Acute kidney injury after high dose etoposide phosphate: a retrospective study in children receiving an allogeneic hematopoetic stem cell transplantation","volume":"65","author":"Barnoud","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R19-20230913","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/sj.bmt.1704144","article-title":"Acute renal failure requiring dialysis after allogeneic blood and marrow transplantation identifies very poor prognosis patients","volume":"32","author":"Hahn","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"R20-20230913","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1159\/000168889","article-title":"Acute renal failure in patients following bone marrow transplantation: prevalence, risk factors and outcome","volume":"15","author":"Gruss","year":"1995","journal-title":"Am J Nephrol"},{"key":"R21-20230913","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1177\/106002809402801125","article-title":"Lack of nephrotoxicity with the administration of amphotericin B in a lipid emulsion","volume":"28","author":"Smith","year":"1994","journal-title":"Ann Pharmacother"},{"key":"R22-20230913","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1053\/j.ajkd.2005.02.010","article-title":"Antiviral drug-induced nephrotoxicity","volume":"45","author":"Izzedine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R23-20230913","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ki.2010.337","article-title":"New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of view","volume":"79","author":"Lopez-Novoa","year":"2011","journal-title":"Kidney Int"},{"key":"R24-20230913","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1097\/01.CCM.0000134832.11144.CB","article-title":"Effect of once-daily dosing vs. multiple daily dosing of tobramycin on enzyme markers of nephrotoxicity","volume":"32","author":"Olsen","year":"2004","journal-title":"Crit Care Med"},{"key":"R25-20230913","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.bbmt.2017.12.799","article-title":"Acute kidney injury in hematopoietic cell transplantation patients receiving vancomycin and piperacillin\/tazobactam versus vancomycin and cefepime","volume":"24","author":"Clemmons","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-20230913","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.bmt.1705454","article-title":"Replacement of calcineurin inhibitors with daclizumab in patients with transplantation-associated microangiopathy or renal insufficiency associated with graft-versus-host disease","volume":"38","author":"Wolff","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"R27-20230913","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R28-20230913","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1681\/ASN.V661655","article-title":"Marked enzymuria after bone marrow transplantation: a correlate of veno-occlusive disease-induced \u201chepatorenal syndrome\u201d","volume":"6","author":"Fink","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R29-20230913","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R30-20230913","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood.V85.11.3005.bloodjournal85113005","article-title":"The syndrome of hepatic veno-occlusive disease after marrow transplantation","volume":"85","author":"Bearman","year":"1995","journal-title":"Blood"},{"key":"R31-20230913","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1111\/ijlh.12137","article-title":"Measurement of circulating endothelial cells to support the diagnosis of veno-occlusive disease after hematopoietic stem cell transplantation","volume":"36","author":"Moiseev","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"R32-20230913","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbmt.2010.02.009","article-title":"Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial","volume":"16","author":"Richardson","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R33-20230913","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/bmt.2015.52","article-title":"Sinusoidal obstruction syndrome\/veno-occlusive disease: current situation and perspectives\u2014a position statement from the European Society for Blood and Marrow Transplantation (EBMT)","volume":"50","author":"Mohty","year":"2015","journal-title":"Bone Marrow Transplant"},{"key":"R34-20230913","doi-asserted-by":"crossref","first-page":"36","DOI":"10.12659\/AOT.883811","article-title":"Safety and effects of prophylactic defibrotide for sinusoidal obstruction syndrome in hematopoietic stem cell transplantation","volume":"18","author":"Park","year":"2013","journal-title":"Ann Transplant"},{"key":"R35-20230913","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multiorgan failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"R36-20230913","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1038\/bmt.2013.101","article-title":"Experiences of t-PA use in moderate-to-severe hepatic veno-occlusive disease after hematopoietic SCT: is it still reasonable to use t-PA?","volume":"48","author":"Yoon","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"R37-20230913","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1056\/NEJM198502283120901","article-title":"Adenovirus infections in patients undergoing bone-marrow transplantation","volume":"312","author":"Shields","year":"1985","journal-title":"N Engl J Med"},{"key":"R38-20230913","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/sj.bmt.1703083","article-title":"Adenoviral infection after allogeneic stem cell transplantation (SCT): report on 130 patients from a single SCT unit involved in a prospective multi center surveillance study","volume":"28","author":"Runde","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"R39-20230913","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jiac.2016.01.013","article-title":"Successful treatment with intravesical cidofovir for virus-associated hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation: a case report and a review of the literature","volume":"22","author":"Sakurada","year":"2016","journal-title":"J Infect Chemother"},{"key":"R40-20230913","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/01.TP.0000122421.71556.71","article-title":"Adenovirus nephritis in hematopoietic stem-cell transplantation","volume":"77","author":"Bruno","year":"2004","journal-title":"Transplantation"},{"key":"R41-20230913","first-page":"873","article-title":"Hydronephrosis in children after bone marrow transplantation","volume":"17","author":"Kapelushnik","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R42-20230913","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM198607243150405","article-title":"Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants","volume":"315","author":"Arthur","year":"1986","journal-title":"N Engl J Med"},{"key":"R43-20230913","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1177\/0300060517691795","article-title":"Incidence, risk factors and the effect of polyomavirus infection in hematopoietic stem cell transplant recipients","volume":"45","author":"Hu","year":"2017","journal-title":"J Int Med Res"},{"key":"R44-20230913","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.bbmt.2014.04.017","article-title":"Relationship of BK polyoma virus (BKV) in the urine with hemorrhagic cystitis and renal function in recipients of T Cell-depleted peripheral blood and cord blood stem cell transplantations","volume":"20","author":"Lee","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R45-20230913","doi-asserted-by":"crossref","DOI":"10.1177\/2399369319858362","article-title":"BK polyoma virus nephropathy in hematopoietic cell transplant recipients","author":"Lee","year":"2019","journal-title":"J Onco-Nephrol"},{"key":"R46-20230913","first-page":"1038.e1","article-title":"BK virus infection is associated with hematuria and renal impairment in recipients of allogeneic hematopoetic stem cell transplants","volume":"15","author":"O\u2019Donnell","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R47-20230913","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1386-6532(99)00055-4","article-title":"Human polyomavirus BK (BKV) load and haemorrhagic cystitis in bone marrow transplantation patients","volume":"14","author":"Azzi","year":"1999","journal-title":"J Clin Virol"},{"key":"R49-20230913","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1053\/j.ajkd.2014.11.020","article-title":"Brincidofovir for polyomavirus-associated nephropathy after allogeneic hematopoietic stem cell transplantation","volume":"65","author":"Papanicolaou","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"R50-20230913","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2018.06.013","article-title":"Emerging concepts in hematopoietic stem cell transplantation-associated renal thrombotic microangiopathy and prospects for new treatments","volume":"72","author":"Wanchoo","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"R51-20230913","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2215\/CJN.00620117","article-title":"Thrombotic microangiopathy and the kidney","volume":"13","author":"Brocklebank","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R52-20230913","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nrneph.2012.195","article-title":"STEC-HUS atypical HUS and TTP are all diseases of complement activation","volume":"8","author":"Noris","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R53-20230913","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1182\/blood-2015-08-663435","article-title":"The genetic fingerprint of susceptibility for transplant-associated thrombotic microangiopathy","volume":"127","author":"Jodele","year":"2016","journal-title":"Blood"},{"key":"R54-20230913","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/bmt.2017.119","article-title":"Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD","volume":"52","author":"Zeisbrich","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"R55-20230913","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.1016\/j.bbmt.2010.12.316","article-title":"Does early initiation of therapeutic plasma exchange affect outcome in pediatric stem cell transplant-associated thrombotic microangiopathy?","volume":"17","author":"Jodele","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"R56-20230913","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2018.08.016","article-title":"Therapeutic plasma exchange does not improve renal function in hematopoietic stem cell transplantation-associated thrombotic microangiopathy: an institutional experience","volume":"25","author":"Sartain","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"R57-20230913","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.bbmt.2013.12.565","article-title":"Eculizumab therapy in children with severe hematopoietic stem cell transplantation\u2013associated thrombotic microangiopathy","volume":"20","author":"Jodele","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R58-20230913","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.blre.2014.11.001","article-title":"A new paradigm: diagnosis and management of HSCT-associated thrombotic microangiopathy as multisystem endothelial injury","volume":"29","author":"Jodele","year":"2015","journal-title":"Blood Rev"},{"key":"R59-20230913","doi-asserted-by":"crossref","first-page":"12","DOI":"10.2215\/CJN.01840214","article-title":"Urinary elafin and kidney injury in hematopoietic cell transplant recipients","volume":"10","author":"Hingorani","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"R60-20230913","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.bbmt.2014.08.022","article-title":"Urinary liver-type fatty acid-binding protein linked with increased risk of acute kidney injury after allogeneic stem cell transplantation","volume":"20","author":"Shingai","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"R61-20230913","first-page":"1150","article-title":"Early identification of acute kidney injury after hematopoietic stem cell transplantation by the measurement of urinary biomarkers","volume":"53","author":"Morito","year":"2011","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"R62-20230913","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/s41409-018-0428-6","article-title":"A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation","volume":"54","author":"Benoit","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"R63-20230913","article-title":"Early diagnostic markers for detection of acute kidney injury in allogeneic hematopoietic stem cell transplant recipients","author":"Deger","year":"2017","journal-title":"Exp Clin Transplant"},{"key":"R64-20230913","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.bbmt.2013.09.005","article-title":"Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation","volume":"19","author":"Arai","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R65-20230913","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2013.08.018","article-title":"Unique considerations in renal replacement therapy in children: core curriculum","volume":"63","author":"Sethi","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R66-20230913","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1523-1755.2005.67121.x","article-title":"Pediatric patients with multiorgan dysfunction syndrome receiving continuous renal replacement therapy","volume":"67","author":"Goldstein","year":"2005","journal-title":"Kidney Int"},{"key":"R67-20230913","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1007\/s12185-018-2536-x","article-title":"Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation","volume":"108","author":"Nakamura","year":"2018","journal-title":"Int J Hematol"},{"key":"R68-20230913","doi-asserted-by":"crossref","DOI":"10.1111\/petr.13139","article-title":"The role of continuous renal replacement therapy in the management of acute kidney injury associated with sinusoidal obstruction syndrome following hematopoietic cell transplantation","volume":"22","author":"Raina","year":"2018","journal-title":"Pediatr Transplant"},{"key":"R69-20230913","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00467-007-0672-2","article-title":"Continuous renal replacement therapy (CRRT) after stem cell transplantation. A report from the prospective pediatric CRRT Registry Group","volume":"23","author":"Flores","year":"2008","journal-title":"Pediatr Nephrol"}],"container-title":["Current Opinion in Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000657","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:37:08Z","timestamp":1694633828000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MCC.0000000000000657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":68,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/mcc.0000000000000657","relation":{},"ISSN":["1070-5295","1531-7072"],"issn-type":[{"value":"1070-5295","type":"print"},{"value":"1531-7072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}